Trial Profile
Sex differences in the pharmacokinetics and bioequivalence of the delayed-release combination of doxylamine succinate-pyridoxine hydrochloride; implications for pharmacotherapy in pregnancy.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 Dec 2015
Price :
$35
*
At a glance
- Drugs Doxylamine/pyridoxine (Primary)
- Indications Morning sickness
- Focus Pharmacokinetics
- 25 Dec 2015 New trial record